Search research articles
Contact Us
Filters
Showing results (311-320 of 333) with videos related to
Page
of 34
Sort By:
Journal of Hepatology
|
September 21, 2014
Randomized study of danoprevir/ritonavir-based therapy for HCV genotype 1 patients with prior partial or null responses to peginterferon/ribavirin
Jordan J Feld, Ira M Jacobson, Donald M Jensen, et al.
Alimentary Pharmacology & Therapeutics
|
September 9, 2025
Prediction of Hepatocellular Carcinoma and Other Liver-Related Events in Chronic Hepatitis B Patients With Metabolic Dysfunction or Metabolic Dysfunction-Associated Steatotic Liver Disease
Lesley A Patmore, Ivana Carey, Jordan J Feld, et al.
The International Journal on Drug Policy
|
November 2, 2018
Paritaprevir, ritonavir, ombitasvir, and dasabuvir with and without ribavirin in people with HCV genotype 1 and recent injecting drug use or receiving opioid substitution therapy
Jason Grebely, Brian Conway, Evan B Cunningham, et al.
The International Journal on Drug Policy
|
October 24, 2018
Adherence to sofosbuvir and velpatasvir among people with chronic HCV infection and recent injection drug use: The SIMPLIFY study
Evan B Cunningham, Janaki Amin, Jordan J Feld, et al.
Journal of Hepatology
|
October 27, 2016
Risk of cirrhosis-related complications in patients with advanced fibrosis following hepatitis C virus eradication
Adriaan J van der Meer, Jordan J Feld, Harald Hofer, et al.
Gastroenterology
|
December 20, 2015
Hepatitis B Virus--Specific and Global T-Cell Dysfunction in Chronic Hepatitis B
Jang-June Park, David K Wong, Abdus S Wahed, et al.
The Lancet. Respiratory Medicine
|
October 14, 2019
Prevention of viral transmission during lung transplantation with hepatitis C-viraemic donors: an open-label, single-centre, pilot trial
Marcelo Cypel, Jordan J Feld, Marcos Galasso, et al.
The Lancet. Gastroenterology & Hepatology
|
January 10, 2018
Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial
Jason Grebely, Olav Dalgard, Brian Conway, et al.
The American Journal of Gastroenterology
|
January 31, 2023
Incidence of Hepatic Decompensation After Nucleos(t)ide Analog Withdrawal: Results From a Large, International, Multiethnic Cohort of Patients With Chronic Hepatitis B (RETRACT-B Study)
Grishma Hirode, Bettina E Hansen, Chien-Hung Chen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
July 21, 2022
Differential Relapse Patterns After Discontinuation of Entecavir vs Tenofovir Disoproxil Fumarate in Chronic Hepatitis B
Hannah S J Choi, Grishma Hirode, Chien-Hung Chen, et al.
Page
of 34
Search research articles
Search
Showing results (311-320 of 333) with videos related to
Sort By:
Page
of 34
Journal of Hepatology
|
September 21, 2014
Randomized study of danoprevir/ritonavir-based therapy for HCV genotype 1 patients with prior partial or null responses to peginterferon/ribavirin
Jordan J Feld, Ira M Jacobson, Donald M Jensen, et al.
Alimentary Pharmacology & Therapeutics
|
September 9, 2025
Prediction of Hepatocellular Carcinoma and Other Liver-Related Events in Chronic Hepatitis B Patients With Metabolic Dysfunction or Metabolic Dysfunction-Associated Steatotic Liver Disease
Lesley A Patmore, Ivana Carey, Jordan J Feld, et al.
The International Journal on Drug Policy
|
November 2, 2018
Paritaprevir, ritonavir, ombitasvir, and dasabuvir with and without ribavirin in people with HCV genotype 1 and recent injecting drug use or receiving opioid substitution therapy
Jason Grebely, Brian Conway, Evan B Cunningham, et al.
The International Journal on Drug Policy
|
October 24, 2018
Adherence to sofosbuvir and velpatasvir among people with chronic HCV infection and recent injection drug use: The SIMPLIFY study
Evan B Cunningham, Janaki Amin, Jordan J Feld, et al.
Journal of Hepatology
|
October 27, 2016
Risk of cirrhosis-related complications in patients with advanced fibrosis following hepatitis C virus eradication
Adriaan J van der Meer, Jordan J Feld, Harald Hofer, et al.
Gastroenterology
|
December 20, 2015
Hepatitis B Virus--Specific and Global T-Cell Dysfunction in Chronic Hepatitis B
Jang-June Park, David K Wong, Abdus S Wahed, et al.
The Lancet. Respiratory Medicine
|
October 14, 2019
Prevention of viral transmission during lung transplantation with hepatitis C-viraemic donors: an open-label, single-centre, pilot trial
Marcelo Cypel, Jordan J Feld, Marcos Galasso, et al.
The Lancet. Gastroenterology & Hepatology
|
January 10, 2018
Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial
Jason Grebely, Olav Dalgard, Brian Conway, et al.
The American Journal of Gastroenterology
|
January 31, 2023
Incidence of Hepatic Decompensation After Nucleos(t)ide Analog Withdrawal: Results From a Large, International, Multiethnic Cohort of Patients With Chronic Hepatitis B (RETRACT-B Study)
Grishma Hirode, Bettina E Hansen, Chien-Hung Chen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
July 21, 2022
Differential Relapse Patterns After Discontinuation of Entecavir vs Tenofovir Disoproxil Fumarate in Chronic Hepatitis B
Hannah S J Choi, Grishma Hirode, Chien-Hung Chen, et al.
Page
of 34